Trial Profile
Long-term use and Clinical Outcomes of Clopidogrel, Prasugrel, or Ticagrelor in patients with Acute Coronary Syndrome in Austria
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2017
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 15 Dec 2017 New trial record